Quote | Super Quote
Future News

06/10/2026 09:39

Zai Lab rises 6%, Genscript up 5%, overnight tech strength lifts biotech index 2%

   Hong Kong stocks rebounded today, with the Hang Seng Index currently at 24,303, up 263 points or 1.1%, driving the biotech sector higher. Zai Lab (09688) rose 5.6% to HK$20.14; Genscript Biotech (01548) gained 4.9% to HK$47.86; China Biologic Products (01177) advanced 2.3% to HK$5.68; WuXi Biologics (02269) climbed 2.7% to HK$56.9.

  Overnight, U.S. tech stocks performed well, with Meta (US.META) up 1.9%; Microsoft (US.MSFT) up 1.5%; Alphabet (US.GOOGL) up 0.9%; NVIDIA (US.NVDA) up 2.1%, reaching a new high; SpaceX (US.SPCX) CEO's secretary Musk announced renaming its AI business to "SpaceXAI"; subsequently, Morgan Stanley followed up on SpaceX's business development, stating that after considering the growth potential brought by the launch of AI, space, and cloud products, SpaceX's stock remains undervalued, driving its overnight share price up 7.6%. Strong tech performance pushed the Nasdaq Composite to close above 1%, hitting a record high of 27,477.31 points.

  Current main board turnover exceeds HK$17.9 billion. The Hang Seng China Enterprises Index stands at 8,143, up 91 points or 1.1%. The Hang Seng Tech Index is at 4,233, up 50 points or 1.2%.
 
Table showing performance of related stocks in the same sector
Stock (Code)Current Price (HK$)Change (%)
Zai Lab (09688)20.14Up 5.61%
Derqui-B (02526)263.2Up 4.86%
Genscript Biotech (01548)47.86Up 4.86%
Ascentage Pharma (06855)28.98Up 3.35%
Hansoh Pharmaceutical (03692)34.76Up 2.18%
China Biologic Products (01177)5.68Up 2.34%
WuXi Biologics (02269)56.9Up 2.71%
XTAL Pi (02228)8.05Up 2.68%
Alphamab Oncology (09926)108Up 1.89%
(am)
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.